Taken together, these results show that the type of cell death induced by RSL3 treatment in NSCLC cells is ferroptosis, and that RSL3 also causes the suppression of GPX4 and induction of the Nrf2/HO1 pathway. Here, GPX4 is linked to non-small cell lung carcinoma.